Lovastatin therapy in familial dysbetalipoproteinemia: Effects on kinetics of apolipoprotein B
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 70 (1-2) , 131-143
- https://doi.org/10.1016/0021-9150(88)90107-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.Journal of Clinical Investigation, 1985
- Influence of obesity on the metabolism of apolipoprotein B in humans.Journal of Clinical Investigation, 1985
- Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.Journal of Clinical Investigation, 1985
- Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.Journal of Clinical Investigation, 1984
- Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.Journal of Clinical Investigation, 1981
- Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.Journal of Clinical Investigation, 1979
- Polymorphism of apolipoprotein EClinical Genetics, 1979
- The Theory of Tracer Experiments with 131I-Labelled Plasma ProteinsPhysics in Medicine & Biology, 1957